FDA NDC Directory · JSON-LD · Markdown

Bortezomib

NDC 70069-836 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebortezomib
Labeler / ManufacturerSomerset Therapeutics LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA211898
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (3.5 mg/3.5mL)
Marketing started20250429
Package count1

External sources

Source: openFDA. Public-domain (CC0).